Robertson Stephens Wealth Management’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Robertson Stephens Wealth Management’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.6K	Hold	12,000	–	–	﹤0.01%	639
2026 Q2	$12.5K	Hold	12,000	–	–	﹤0.01%	644
2026 Q1	$12.7K	Sell	12,000 -14,000	-54%	-$1.05K	﹤0.01%	614
2025 Q4	$40.6K	Buy	+26,000	New	+$2.69K	﹤0.01%	636

Robertson Stephens Wealth Management's ESLAW Position: Q3 2026 in Review

Robertson Stephens Wealth Management held its Estrella Immunopharma Warrant (ESLAW) position steady in Q3 2026 at 12,000 shares worth $5.6K. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Robertson Stephens Wealth Management first reported a position in ESLAW in Q4 2025 and has held it in 4 quarters since. The position peaked at $40.6K in Q4 2025. 1 fund tracked by Wall St. Rank holds ESLAW as of Q3 2026.

Robertson Stephens Wealth Management held 12,000 shares of Estrella Immunopharma Warrant worth $5.6K as of Q3 2026.
Robertson Stephens Wealth Management left its Estrella Immunopharma Warrant share count unchanged in Q3 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of Robertson Stephens Wealth Management's portfolio in Q3 2026, its #639 holding.
Robertson Stephens Wealth Management first reported a position in Estrella Immunopharma Warrant in Q4 2025 and has held it in 4 quarters since.
Robertson Stephens Wealth Management's Estrella Immunopharma Warrant position peaked at $40.6K in Q4 2025.
1 fund tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q3 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.